Clinical Trial

SCAD : a Registry of Spontaneous Coronary Artery Dissection

Study acronym: SCAD
Recruiting
View on ClinicalTrials.gov →
Summary
Spontaneous coronary artery dissection (SCAD) is an increasingly recognised cause of non-atherosclerotic acute coronary syndromes (ACS), predominantly afflicting young women without conventional atherosclerotic risk factors. Knowledge of SCAD has advanced considerably in the last few years as a result of data from a number of local and national registries 1-6. Like all rarer diseases however, a better understanding of SCAD will require international collaboration. At present, there is no European or International SCAD registry despite increasing recognition that there are key differences in the diagnosis, interventional and medical management of SCAD compared with conventional atherosclerotic ACS. The ESC-ACCA Study Group on Spontaneous Coronary Artery Dissection supported by the European Observational Research Programme will now build the first pan-European SCAD registry to advance our understanding of current management of this condition, inform guidelines, educate clinical colleagues and advance research.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-13.
Trial Details
NCT Number NCT06601270
Lead Sponsor European Society of Cardiology
Conditions Spontaneous Coronary Artery Dissection
Enrollment 1,500 participants
Start Date 2021-01-30
Primary Completion 2026-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2024-10-29